Fotivda Capsule
Product Images NDC 45629-089
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fotivda (NDC 45629-089). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aveo Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Fotivda 02)
This is a survival plot of two treatment groups "FOTIVDA" and "SORAFENIB" evaluated over 24 months. The plot shows the number of subjects at risk vs. survival time (in months) for each group. The survival time range is from 0 to 24 months. "FOTIVDA" treatment group has 173 subjects at risk and "SORAFENIB" has 175 subjects at risk. The data suggests that "FOTIVDA" may have a better survival rate than the "SORAFENIB" treatment group.*
Principal Display Panel (0.89 mg Capsule Bottle Label)
Each capsule of FOTIVDA® contains 089 mg. The prescription information and storage details are provided by AVED Pharmaceuticals. The NDC code for this product is 45629-083-01. The storage temperature should be between 15°C to 30°C (59°F to 86°F) in a controlled room. Keep away from moisture and store at room temperature. Any other information regarding the usage and purpose of the product is not available.*
Principal Display Panel (1.34 mg Capsule Bottle Label)
The text provides information for a drug called FOTIVDA, manufactured by Catalnt cTs I for AVEO Pharmaceutical, Boston. Each capsule contains 134 mg of tivozanib hydrochloride equivalent to 1.5mg of tivozanib. The recommended dosage and other prescription information is not available. The drug should be stored at a temperature between 20°C to 25°C; with excursions permitted at 15°C to 30°C. It should be kept out of reach of children. The package comes with only 21 capsules, and the National Drug Code is 45629-134-01.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.